However, despite the numerous evidence on the role of HOTAIR as a diagnostic and prognostic marker in the majority of solid tumors, only one clinical trial performed on thyroid cancer patients (ClinicalTrials.gov Identifier: NCT03469544) is ongoing. The gene discussed is HOTAIR; the disease is thyroid gland carcinoma.